Anterix Inc. (NASDAQ:ATEX - Get Free Report) saw a significant drop in short interest in November. As of November 30th, there was short interest totalling 616,300 shares, a drop of 11.0% from the November 15th total of 692,700 shares. Based on an average trading volume of 182,400 shares, the days-to-cover ratio is currently 3.4 days.
Anterix Trading Down 1.2 %
Anterix stock traded down $0.39 during midday trading on Friday, hitting $33.51. The stock had a trading volume of 60,121 shares, compared to its average volume of 151,185. The business has a fifty day moving average price of $33.48 and a 200 day moving average price of $35.71. Anterix has a 12 month low of $29.12 and a 12 month high of $42.41. The stock has a market cap of $623.89 million, a P/E ratio of -16.59 and a beta of 0.85.
Analyst Upgrades and Downgrades
Separately, Craig Hallum upgraded shares of Anterix to a "strong-buy" rating in a research note on Wednesday, October 9th.
Read Our Latest Research Report on Anterix
Insider Buying and Selling at Anterix
In other Anterix news, Director Mark Fleischhauer purchased 3,500 shares of Anterix stock in a transaction that occurred on Thursday, December 5th. The stock was purchased at an average price of $34.19 per share, with a total value of $119,665.00. Following the completion of the acquisition, the director now owns 3,500 shares of the company's stock, valued at approximately $119,665. This trade represents a ∞ increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Leslie B. Daniels acquired 2,000 shares of the company's stock in a transaction on Wednesday, November 20th. The shares were acquired at an average price of $32.75 per share, for a total transaction of $65,500.00. Following the completion of the acquisition, the director now directly owns 2,000 shares in the company, valued at $65,500. The trade was a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. 45.61% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Anterix
A number of institutional investors have recently made changes to their positions in ATEX. Allspring Global Investments Holdings LLC acquired a new position in Anterix in the second quarter worth $28,000. nVerses Capital LLC acquired a new position in shares of Anterix in the 3rd quarter valued at about $45,000. Meeder Asset Management Inc. bought a new stake in shares of Anterix during the 3rd quarter valued at about $58,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Anterix during the second quarter worth about $92,000. Finally, Point72 DIFC Ltd raised its stake in Anterix by 440.8% during the third quarter. Point72 DIFC Ltd now owns 2,639 shares of the company's stock worth $99,000 after acquiring an additional 2,151 shares during the period. 87.67% of the stock is currently owned by institutional investors.
Anterix Company Profile
(
Get Free Report)
Anterix Inc operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico.
Recommended Stories
Before you consider Anterix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anterix wasn't on the list.
While Anterix currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.